{
  "documents": [
    {
      "id": "cluster_38_doc1",
      "content": "Austin Allergy Center submitted claim 4782-331 for a 32-year-old patient with seasonal allergies receiving immunotherapy injections. The claim includes details of three visits between March-April 2023 with copay amounts of $40 per session. Treatment plan authorization was approved under policy group TX-ALL-2022.",
      "metadata": {
        "format": "claim_form"
      }
    },
    {
      "id": "cluster_38_doc2",
      "content": "Clinical notes from Travis County Health indicate a patient with comorbid seasonal allergies and migraines showed improvement after 12 weeks of sublingual immunotherapy. Concurrent prescription for antihistamines was refilled twice during observation period. Next follow-up scheduled for July 2023.",
      "metadata": {
        "format": "medical_record"
      }
    },
    {
      "id": "cluster_38_doc3",
      "content": "Internal memo regarding policy update 23-ALG-REF: Effective June 2023, Travis County providers must document treatment duration expectations before authorizing extended allergy immunotherapy. Implementation impacts approximately 15% of current authorization requests.",
      "metadata": {
        "format": "insurance_memo"
      }
    },
    {
      "id": "cluster_38_doc4",
      "content": "Research brief: Patients completing full 3-year allergy immunotherapy course in Central Texas demonstrated 60% reduction in related medication usage. Study period covered 2020-2023 across 8 clinics. Demographic breakdown showed highest adherence rates in 30-39 age group.",
      "metadata": {
        "format": "research_note"
      }
    },
    {
      "id": "cluster_38_doc5",
      "content": "Local news report: Austin area sees 20% increase in allergy-related insurance denials following policy changes. Health advocates cite disparities in accessing newer immunotherapy options, particularly affecting residents in Travis County's northern districts.",
      "metadata": {
        "format": "news_article"
      }
    }
  ],
  "metadata": {
    "category": "cluster",
    "cluster_id": "cluster_38",
    "cluster_risk": "LOW",
    "content_summary": "Documentation related to allergy treatment protocols, insurance claims, and policy changes affecting Travis County patients",
    "person": {
      "entities": [
        [
          "32",
          "AGE"
        ],
        [
          "seasonal allergies",
          "MEDICAL_CONDITION"
        ],
        [
          "migraines",
          "MEDICAL_CONDITION"
        ],
        [
          "immunotherapy injections",
          "TREATMENT"
        ],
        [
          "sublingual immunotherapy",
          "TREATMENT"
        ],
        [
          "antihistamines",
          "TREATMENT"
        ],
        [
          "three visits",
          "EVENT"
        ],
        [
          "March-April 2023",
          "EVENT_DATE"
        ],
        [
          "July 2023",
          "EVENT_DATE"
        ]
      ]
    },
    "questions": [
      {
        "q": "What was the copay amount for immunotherapy sessions at Austin Allergy Center during March-April 2023?",
        "a": "$40 per immunotherapy session.",
        "sources": [
          "cluster_38_doc1"
        ],
        "type": "specific"
      },
      {
        "q": "What policy change was implemented in June 2023 affecting allergy immunotherapy authorizations in Travis County?",
        "a": "Policy required treatment duration documentation.",
        "sources": [
          "cluster_38_doc3"
        ],
        "type": "general"
      },
      {
        "q": "What treatment improvement was observed for the 32-year-old patient with seasonal allergies and migraines, and what percentage reduction in medication usage was reported for patients completing a full 3-year allergy immunotherapy course?",
        "a": "12 weeks sublingual immunotherapy; 60% medication reduction after 3-year course.",
        "sources": [
          "cluster_38_doc2",
          "cluster_38_doc4"
        ],
        "type": "specific"
      },
      {
        "q": "What policy change was implemented in June 2023 affecting allergy immunotherapy authorizations, and what denial trend followed this change?",
        "a": "Policy required treatment duration documentation; denials rose 20% in northern districts.",
        "sources": [
          "cluster_38_doc3",
          "cluster_38_doc5"
        ],
        "type": "general"
      }
    ]
  }
}